CD8A and neoplasm: Multiplex IHC images showed that mice receiving TPX therapy displayed reduced tumor-infiltrating Arg1+ M2 macrophages and Foxp3+ Treg cells, whereas the frequency of CD8+ cytotoxic T lymphocytes was not changed (Figure 5B,C).